Nuformix (LON:NFX) Trading 18.8% Higher – Still a Buy?

Nuformix plc (LON:NFX)’s share price was up 18.8% on Friday . The company traded as high as GBX 0.06 ($0.00) and last traded at GBX 0.06 ($0.00). Approximately 47,841,488 shares changed hands during mid-day trading, an increase of 195% from the average daily volume of 16,233,574 shares. The stock had previously closed at GBX 0.05 ($0.00).

Nuformix Price Performance

The stock’s 50 day moving average price is GBX 0.05 and its two-hundred day moving average price is GBX 0.11. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.12 and a quick ratio of 3.35. The firm has a market capitalization of £475,199.80, a price-to-earnings ratio of -1.63 and a beta of 1.22.

About Nuformix

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.